Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Sep 1;20(5):367-372.
doi: 10.1001/jamafacial.2018.0230.

Novel Use of a Volumizing Hyaluronic Acid Filler for Treatment of Infraorbital Hollows

Michael B Hall  1 , Sudeep Roy  1 , Edward D Buckingham  1
Affiliations
Observational Study

Novel Use of a Volumizing Hyaluronic Acid Filler for Treatment of Infraorbital Hollows

Michael B Hall et al. JAMA Facial Plast Surg. .

Abstract

Importance: Hyaluronic acid filler can be safely used as a soft-tissue filler for correction of infraorbital hollowing. It has a high overall patient satisfaction profile among patients.

Objective: To report safety and patient satisfaction outcomes of Juvéderm Voluma XC for correction of infraorbital hollows.

Design, setting, and patients: This was a retrospective observational study performed at a private ambulatory facial plastic and reconstructive surgery practice. Participants were all patients 21 to 85 years old who presented to our practice and underwent Juvéderm Voluma XC treatment for correction of infraorbital hollows as a singular intervention from February 2016 to March 2017.

Interventions: Injection of Juvéderm Voluma XC to the tear trough, nasojugal fold, and/or palpebromalar groove.

Main outcomes and measures: Primary outcome measures include the number of recorded short- and long-term adverse events, need for additional treatment, and patient questionnaire FACE-Q scores.

Results: A total of 202 eyes were treated in 101 patients with a mean follow-up of 12 months. Patients were principally female (90 [89%]) with an average age of 54 years (range, 21-85 years). Most patients (99) had Fitzpatrick grade 1 to 4 skin type (98%) and had an infraorbital hollows score of 2 to 4 (89 [88%]). The average initial treatment volume was 1 mL with 18 patients (18%) requiring additional treatment within 3 months. The average time until additional treatment was 35.7 days. Adverse effects include bruising (in 10 [10%], contour irregularities (2 [2%]), swelling (3 [3%]), and Tyndall effect (1 [1%]). Hyaluronidase was required in 3 patients (3%). Forty-one patients completed the FACE-Q Satisfaction With Eyes survey, and 42 patients completed the FACE-Q Satisfaction With Decision survey (41% and 42%). Overall mean (SD) patient satisfaction (based on FACE-Q scores) was 71.1% (27.3) and 65.6% (31.3), respectively.

Conclusions and relevance: Juvéderm Voluma XC has a high patient satisfaction profile and an acceptable safety profile for the correction of infraorbital hollowing.

Level of evidence: 4.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. FACE-Q Satisfaction Results for 101 Patients
Figure 2.
Figure 2.. Anatomy of Infraorbital Hollowing
Figure 3.
Figure 3.. Before and After Juvéderm Voluma XC Treatment
The patient had 0.5 mL of Voluma injected in each lower eyelid.
See this image and copyright information in PMC

Comment in

References

    1. Bravo BS, Rocha CR, Bastos JT, Silva PM. Comprehensive treatment of periorbital region with hyaluronic acid. J Clin Aesthet Dermatol. 2015;8(6):30-35. - PMC - PubMed
    1. Finn JC, Cox S. Fillers in the periorbital complex. Facial Plast Surg Clin North Am. 2007;15(1):123-132, viii. - PubMed
    1. Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013;39(11):1602-1612. - PubMed
    1. Bogdan Allemann I, Baumann L. Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging. 2008;3(4):629-634. - PMC - PubMed
    1. Callan P, Goodman GJ, Carlisle I, et al. . Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol. 2013;6:81-89. - PMC - PubMed

Publication types

MeSH terms